Location: Bangalore, Karnataka
Experience: 1–3 years
Qualification: MBBS or MD
Industry: Pharmaceutical & Healthcare
Job Type: Full-time
Job Description
Arcolab, a leading name in the pharmaceutical industry, is hiring a Medical Reviewer – Pharmacovigilance to join its drug safety team in Bangalore. This role is critical in ensuring patient safety and regulatory compliance by reviewing and analyzing adverse event reports.
Key Responsibilities:
✔ Conduct medical review of Individual Case Safety Reports (ICSRs) from clinical trials, spontaneous reports, and literature.
✔ Perform causality assessment and evaluate clinical relevance of adverse drug reactions (ADRs).
✔ Identify and escalate potential safety signals for further investigation.
✔ Ensure compliance with ICH E2B, MedDRA, and global pharmacovigilance regulations.
✔ Collaborate with cross-functional teams for timely regulatory reporting.
About the Hiring Company – Arcolab
Arcolab is a reputed pharmaceutical organization committed to drug safety, regulatory excellence, and patient well-being. With a strong presence in Bangalore, the company specializes in pharmacovigilance, clinical research, and compliance solutions. Joining Arcolab means being part of a purpose-driven team that prioritizes quality and innovation in healthcare.
Eligibility Criteria
To apply for the Medical Reviewer – Pharmacovigilance position, candidates must meet the following requirements:
📌 Education: MBBS or MD (Pharmacology preferred).
📌 Experience: 1–3 years in ICSR medical review or pharmacovigilance.
📌 Technical Skills: Proficiency in Argus, ARISg, or other safety databases.
📌 Regulatory Knowledge: Familiarity with MedDRA, WHO-DD, and ICH-GCP guidelines.
📌 Soft Skills: Strong analytical thinking, attention to detail, and teamwork.
How to Apply
Interested and eligible candidates can apply by sending their updated resume/CV to:
📩 Email: [dev.kiran@arcolab.com]
📌 Subject Line: “Application for Medical Reviewer – Pharmacovigilance, Bangalore”
Note: Only shortlisted candidates will be contacted for further selection rounds.
